Monaco Asset Management SAM
- SEC CIK
- 0001803593
- Latest filing
- Aug 7, 2026
ESPR holding history
Esperion Therapeutics, Inc. in every 13F filed by Monaco Asset Management SAM, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ESPR overviewAll 13F holders of ESPRFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −243,642−100.0% | Sold out | Holders |
| Q4 2023 | 243,642 | $728.5K | 0.3% | −928,137−79.2% | Reduced | Holders |
| Q3 2023 | 1,171,779 | $1.15M | 0.6% | +476,477+68.5% | Added | Holders |
| Q2 2023 | 695,302 | $966.5K | 0.5% | +551,940+385.0% | Added | Holders |
| Q1 2023 | 143,362 | $227.9K | 0.1% | −326,738−69.5% | Reduced | Holders |
| Q4 2022 | 470,100 | $2.93M | 1.0% | +210,100+80.8% | Added | Holders |
| Q3 2022 | 260,000 | $1.74M | 0.8% | +87,500+50.7% | Added | Holders |
| Q2 2022 | 172,500 | $1.10M | 0.5% | −246,762−58.9% | Reduced | Holders |
| Q1 2022 | 419,262 | $1.95M | 1.0% | −80,738−16.1% | Reduced | Holders |
| Q4 2021 | 500,000 | $2.50M | 1.6% | – | No prior filing | Holders |